triazolam has been researched along with Seizures in 12 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The authors report a case of a 55-year-old man undergoing a triazolam withdrawal syndrome that was recognized and treated with high doses of benzodiazepines, but the patient nevertheless developed seizures." | 7.67 | Seizures following triazolam withdrawal despite benzodiazepine treatment. ( Pawluczyk, S; Schneider, LS; Syapin, PJ, 1987) |
| " Both anticonvulsants tested suppressed seizures in a different manner, however triazolam exerted stronger anticonvulsive activity than the same dose of diazepam did." | 3.69 | Convulsive properties of N-(3,5-dimethoxy-4-propoxyphenyl-ethyl) aziridine and their influencing by diazepam and triazolam. ( Herink, J, 1995) |
| "In this study, we present five cases of seizures following withdrawal of flunitrazepam, lorazepam, or triazolam, representing 3% of a sample consisting of 153 patients dependent on benzodiazepines." | 3.69 | Benzodiazepine withdrawal syndrome seizures. ( de Iceta, M; Martínez-Cano, H; Martínez-Gras, I; Pomalima, R; Vela-Bueno, A, 1995) |
| " The four BZR ligands triazolam, diazepam, Ro 19-8022 (a benzoquinolizinone) and bretazenil (Ro 16-6028, an imidazobenzodiazepinone) were pharmacologically characterized in various neurological and behavioral paradigms in mice: two anticonvulsant tests (prevention of audiogenic and pentylenetetrazol-induced seizures), a conflict test which reveals both anxiolytic and sedative properties and two tests which mainly measure motor impairment (rotarod and horizontal wire test)." | 3.68 | Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies. ( Bonetti, EP; Facklam, M; Haefely, WE; Jenck, F; Martin, JR; Moreau, JL; Schoch, P, 1992) |
| "The authors report a case of a 55-year-old man undergoing a triazolam withdrawal syndrome that was recognized and treated with high doses of benzodiazepines, but the patient nevertheless developed seizures." | 3.67 | Seizures following triazolam withdrawal despite benzodiazepine treatment. ( Pawluczyk, S; Schneider, LS; Syapin, PJ, 1987) |
| " for 14 days) the corresponding dose-response lines were shifted to the right suggesting tolerance development." | 1.27 | Subacute benzodiazepine treatment: observations on behavioural tolerance and withdrawal. ( Gonzalez, JP; McCulloch, AJ; Nicholls, PJ; Sewell, RD; Tekle, A, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (58.33) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gall, M | 1 |
| Lahti, RA | 1 |
| Rudzik, AD | 1 |
| Duchamp, DJ | 1 |
| Chidester, C | 1 |
| Scahill, T | 1 |
| Gonzalez, JP | 1 |
| McCulloch, AJ | 1 |
| Nicholls, PJ | 1 |
| Sewell, RD | 1 |
| Tekle, A | 1 |
| Herink, J | 2 |
| Martínez-Cano, H | 1 |
| Vela-Bueno, A | 1 |
| de Iceta, M | 1 |
| Pomalima, R | 1 |
| Martínez-Gras, I | 1 |
| Facklam, M | 1 |
| Schoch, P | 1 |
| Bonetti, EP | 1 |
| Jenck, F | 1 |
| Martin, JR | 1 |
| Moreau, JL | 1 |
| Haefely, WE | 1 |
| Koupilová, M | 1 |
| Bajgar, J | 1 |
| Piot, O | 1 |
| Betschart, J | 1 |
| Stutzmann, JM | 1 |
| Blanchard, JC | 1 |
| Griffith, JL | 1 |
| Schneider, LS | 1 |
| Syapin, PJ | 1 |
| Pawluczyk, S | 1 |
| Laplane, D | 1 |
| Baulac, M | 1 |
| Lacomblez, L | 1 |
| Patterson, WM | 1 |
| Tien, AY | 1 |
| Gujavarty, KS | 1 |
12 other studies available for triazolam and Seizures
| Article | Year |
|---|---|
Novel anxiolytic agents derived from alpha-amino-alpha-phenyl-o-tolyl-4H-triazoles and -imidazoles.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Brain; Crystallography; Hypnotics and Sedatives; Imid | 1978 |
Subacute benzodiazepine treatment: observations on behavioural tolerance and withdrawal.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Conditioning, Psychological; Diazepam; Drinking Beha | 1984 |
Convulsive properties of N-(3,5-dimethoxy-4-propoxyphenyl-ethyl) aziridine and their influencing by diazepam and triazolam.
Topics: Animals; Anticonvulsants; Aziridines; Diazepam; Male; Rats; Rats, Wistar; Seizures; Triazolam | 1995 |
Benzodiazepine withdrawal syndrome seizures.
Topics: Adult; Anti-Anxiety Agents; Female; Flunitrazepam; Heroin Dependence; Humans; Hypnotics and Sedative | 1995 |
Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies.
Topics: Administration, Oral; Animals; Benzodiazepinones; Diazepam; Dose-Response Relationship, Drug; Female | 1992 |
Effect of triazolam in convulsions induced by pentylenetetrazol.
Topics: Animals; Male; Pentylenetetrazole; Rats; Rats, Inbred Strains; Seizures; Triazolam | 1991 |
Cyclopyrrolones, unlike some benzodiazepines, do not induce physical dependence in mice.
Topics: Animals; Azabicyclo Compounds; Carbolines; Convulsants; Diazepam; Disease Models, Animal; Flunitraze | 1990 |
Treatment of episodic behavioral disorders with rapidly absorbed benzodiazepines.
Topics: Administration, Oral; Adult; Aggression; Anger; Anti-Anxiety Agents; Clorazepate Dipotassium; Diazep | 1985 |
Seizures following triazolam withdrawal despite benzodiazepine treatment.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Chlordiazepoxide; Diazepam; Humans; Male; Middle Aged; Recep | 1987 |
[Convulsions 12 hours after the ingestion of benzodiazepine with a short half-life].
Topics: Adult; Female; Half-Life; Humans; Recurrence; Seizures; Time Factors; Triazolam | 1988 |
Triazolam withdrawal.
Topics: Alprazolam; Diazepam; Drug Tolerance; Humans; Seizures; Substance Withdrawal Syndrome; Triazolam | 1988 |
Seizure following withdrawal from triazolam.
Topics: Adult; Female; Humans; Seizures; Substance Withdrawal Syndrome; Triazolam | 1985 |